Prognostic factors of patients with advanced lung cancer treated with anlotinib: a retrospective cohort study

Objective Our study aimed to evaluate the main factors affecting the efficacy of anlotinib to determine the therapeutically dominant populations. Methods The medical records of patients with lung cancer who were treated with anlotinib from July 2018 to February 2020 at Renji Hospital, School of Medi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bijun Fan, Xiaoming Tan, Yueyan Lou, Yu Zheng, Liyan Zhang, Xueling Wu
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/7ed1120a6a494c16846682beb52de200
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!